HOME >> BIOLOGY >> NEWS
Washington University receives $2.2 million funding from Howard Hughes Medical Institute

St. Louis, July 9, 2002 Washington University in St. Louis is the recipient of a grant from the Howard Hughes Medical Institute (HHMI) intended to enhance undergraduate biology education, graduate teaching skills and the incorporation of emerging scientific disciplines into undergraduate biology education.

Undergraduate biology education is in the midst of a revolution, and 44 research universities will receive $80 million from Howard Hughes Medical Institute (HHMI) to help them address the challenges of a rapidly changing and increasingly interdisciplinary science. The grants will support programs that encourage graduate students and postdoctoral fellows to hone their teaching skills. Other programs will bring emerging scientific disciplines such as genomics and computational biology into the undergraduate curriculum and encourage minorities to pursue careers in science.

The four-year grants to universities in 28 states and the District of Columbia range from $1.2 million to $2.2 million each. A panel of scientists and educators reviewed proposals from 189 institutions.

Washington University, which has been funded by this program since 1992, will receive $2.2 million over four years to provide wide-ranging services and support for undergraduate and K-12 science education. Sarah CR. Elgin, Ph.D., professor of biology, directs the Washington University Undergraduate Biological Sciences Education Program. Washington University was funded at $1.7 million, plus interest, in 1992, $1.4 million in 1994 and $1.7 million in 1998 from the HHMI program.

"The grant will allow us to sustain successful programs in undergraduate research and K-12 science outreach while funding innovative new curriculum in the natural sciences," said Elgin. "We're constantly moving to institutionalize the successful efforts in science education. The willingness of Howard Hughes Medical Institute to provide sustained support is certainly important in realizin
'"/>

Contact: Tony Fitzpatrick
tony_fitzpatrick@aismail.wustl.edu
314-935-5272
Washington University in St. Louis
9-Jul-2002


Page: 1 2 3 4 5

Related biology news :

1. Washington University in St. Louis leads group studying aging process
2. Novel IBD therapeutic approaches reported from Washington Univ., Barcelona, LSU at APS meeting
3. Washington University in St. Louis plays key role in sequencing moss genome
4. APS awards 55 minority travel fellowships to EB 2004 (April 17-21) in Washington, DC
5. Experimental Biology 2004 meets in Washington, D.C. April 17-21
6. Innovative shuttle bus debuts in Washington, D.C.
7. Washington University in St. Louis, Monsanto Co., awarded crop protection patent
8. SARS pre-screening protocol developed for AACR Annual Meeting in Washington, D.C.
9. AACR reschedules annual meeting for July 11-14 in Washington, D.C.
10. Washington-area chemist wins national award for free-radical research
11. Washington university education department receives $10 million NSF grant

Post Your Comments:
(Date:5/21/2013)... shows that the nation,s land and water resources could ... up to 25 billion gallons of algae-based fuel a ... yearly needs. , The findings come from an in-depth ... to grow significant amounts of algae in large, specially ... May 7 issue of Environmental Science and Technology ...
(Date:5/21/2013)... Mo. Cancers of all types become most deadly ... Once cancer has reached this stage, it becomes very ... tumors that can develop. Now, researchers at the University ... nanoparticles that target lymphoma tumor cells wherever they may ... of oncology in the MU College of Veterinary Medicine, ...
(Date:5/21/2013)... is an uphill battle? Try staying fit in space, ... muscle and bone. , That,s the challenge a group ... new three-year, $1.2 million grant from NASA. Their goal ... exploratory missions. , "You could give astronauts the best ... them to stick to it, it isn,t going to ...
Breaking Biology News(10 mins):Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4MU researchers develop radioactive nanoparticles that target cancer cells 2Fueling fitness on the final frontier 2
(Date:5/22/2013)...  Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the ... LLP Microcap Conference, May 30, in New York, ... , CPA, Chief Financial Officer of Cleveland BioLabs, will ... at 1:30 p.m. Eastern Time.  A live and archived webcast ... page of the Cleveland BioLabs website at www.cbiolabs.com . ...
(Date:5/22/2013)... MN (PRWEB) May 22, 2013 ... Medical Supplies Pty Ltd are pleased to announce ... is the Australian and New Zealand distributor of DrugCheck® ... V8 Supercar Team participated in the Austin 400 May ... entered into an agreement that involves each car of ...
(Date:5/22/2013)... A recent study from researchers in Tasmania ... that those who took probiotics were able to run for ... showed that in extreme heat conditions, probiotics were able to ... acne treatment explains what this new discovery means for ... skin condition. , While researchers tote the benefits of ...
(Date:5/21/2013)... May 22, 2013 First patients ... of glycopyrronium bromide designed using Prosonix, particle engineering platform ... a portfolio of inhaled Respiratory Medicines by Design ... PSX1002 that will assess its effect on lung function ... patients with moderate to severe chronic obstructive pulmonary disease ...
Breaking Biology Technology:Cleveland BioLabs to Present at Second Annual Marcum LLP Microcap Conference 2Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team 2Adult Acne Treatment, Probiotic Action Shares Insight on New Findings Between Probiotics and Heat Tolerance, and What It Means for Acne Sufferers 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4
Cached News: